CA125 Can Detect Ovarian Cancer in General Practice
And elevated CA125 indicates higher risk for other cancers, especially in women aged ≥50 years.
Ovarian Cancer
Managing Anemia Associated With Olaparib for Relapsed Ovarian Cancer
What are the recommendations for managing anemia in patients receiving olaparib?
Zejula Approved for Late-line Treatment of Recurrent Ovarian Cancer
Zejula, a poly(ADP-ribose) polymerase (PARP) inhibitor, is also approved for maintenance treatment in adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
PARP Inhibitor Slows Progression of Advanced Ovarian Cancer
Veliparib added to chemotherapy, continued as maintenance tx prolongs progression-free survival.
PTSD Symptoms Tied to Higher Risk for Ovarian Cancer
Correlation moderately attenuated after adjustment for health and ovarian cancer risk factors.
Geriatric Vulnerability Score Validated for Use in Managing Care of Older Patients With Ovarian Cancer
Results of an analysis that validated the use of the GVS to determine vulnerability in older patients with ovarian cancer.
Oophorectomy More Effective Than Ultrasound Screening in Preventing BRCA1-Related Ovarian Cancer
Results of a prospective study comparing effectiveness of ultrasound screening and salpingo-oophorectomy in preventing ovarian cancer are presented.
Germline BRCA2 Mutations Linked to Pediatric Lymphomas
Survivors of NHL should be offered genetic counseling.
Pain Associated With Quality of Life and Survival for Patients With Recurrent Ovarian Cancer
Researchers sought to analyze how pain management affects quality of life and overall survival for patients with recurrent ovarian cancer.
Focus on Ovarian Cancer Surgical Volume May Not Be Best Metric
Minimum-volume standards could restrict care at many centers with better-than-expected outcomes.
Next post in Ovarian Cancer
